Fig. 7From: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancersThe correlation of CDKN2C expression with disease-free interval and progression-free interval of cancer patients. Panels A, C: disease-free interval. Panels B, D: progression-free interval. For panels A and B, p-values are based on univariate Cox gregression analysis; For panels C and D, p-values are based on log-rank testsBack to article page